Oral administration of acidic xylooligosaccharides prevents the development of atopic dermatitis-like skin lesions in NC/Nga mice

J Nutr Sci Vitaminol (Tokyo). 2010;56(1):54-9. doi: 10.3177/jnsv.56.54.

Abstract

We examined whether two types of xylooligosaccharides (neutral or acidic xylooligosaccharides) derived from hardwood kraft pulp ameliorate the development of atopic dermatitis (AD)-like skin lesions induced by repeated application of picryl chloride (PiCl) in NC/Nga mice. Oral administration of acidic xylooligosaccharides at a daily dose of 100 mg/kg significantly prevented the development of AD-like skin lesions. Serum histamine level was significantly suppressed, but serum total IgE level was not significantly suppressed. Moreover, the secretion of inflammatory cytokine IL-12 from splenic lymphocytes was significantly suppressed. On the other hand, neutral xylooligosaccharides showed no significant preventive effect on the development of AD-like symptoms. These results suggest that oral administration of acidic xylooligosaccharides may be effective in preventing the development of AD-like skin disease and one of the mechanisms is the suppressive effect on IL-12.

MeSH terms

  • Acids
  • Administration, Oral
  • Animals
  • Cells, Cultured
  • Dermatitis, Atopic / immunology
  • Dermatitis, Atopic / pathology
  • Dermatitis, Atopic / prevention & control*
  • Histamine / blood
  • Immunoglobulin E / blood
  • Interleukin-12 / metabolism
  • Lymphocytes / drug effects
  • Magnoliopsida*
  • Male
  • Mice
  • Mice, Inbred Strains
  • Oligosaccharides / administration & dosage
  • Oligosaccharides / pharmacology
  • Oligosaccharides / therapeutic use*
  • Phytotherapy*
  • Plant Extracts / administration & dosage
  • Plant Extracts / pharmacology
  • Plant Extracts / therapeutic use*
  • Skin / drug effects*
  • Skin / immunology
  • Skin / pathology
  • Spleen / cytology
  • Wood*

Substances

  • Acids
  • Oligosaccharides
  • Plant Extracts
  • Interleukin-12
  • Immunoglobulin E
  • Histamine